A B S T R A C T Hematopoiesis in the grey collie dog undergoes periodic fluctuations which involve reticulocytes, granulocytes, platelets, lymphocytes, and monocytes. This syndrome is inherited in an autosomal recessive manner and can be transmitted or abolished by appropriate bone marrow transplantation experiments, thus demonstrating this to be a primary marrow defect. Investigation of humoral regulation in this setting indicates that serum erythropoietin (ESF) also undergoes cyclic fluctuation and that shortly after the increase and peak in serum ESF levels recognizable red cell precursors appear in the marrow. Erythropoiesis in the grey collie is reciprocally related to the blood O carrying capacity. With phlebotomy, ESF activity and reticulocytes increase but continue to cycle, while hypertransfusion eliminates reticulocyte production completely. Neither phlebotomy nor hypertransfusion alter the underlying cycle time (11-12 days) nor influence the peaks of peripheral blood granulocytes. Thus, in these experiments, no direct evidence of competition between reticulocyte and granulocyte production is observed. In vitro studies of canine hemoglobin synthesis fail to demonstrate evidence of an inhibitor to ESF. These results indicate that periodic fluctuation of serum ESF is an integral part of the grey collie syndrome and are most consistent with some form of feedback regulation of ESF production.
INTRODUCTION
The grey collie dog is characterized by a genetically determined cyclic variation in the level of blood neutro-
The patterns of fluctuation of the blood elements suggest that this disorder is due to periodic marrow proliferation or cyclic hematopoiesis. Morphologic studies of the bone marrow indicate that recovery from neutropenia results from a wave of myelopoiesis beginning with the earliest recognizable forms. The proliferative recovery of the bone marrow is accompanied by increased tritiated thymidine labeling of myeloid precursors and an increase in serum muramidase levels (3) . Since blood granulocyte survival is normal, the data indicate a failure of granulocyte production occurring at regular intervals (3) . Examination of the bone marrow reveals that changes in erythropoiesis parallel those in granulopoiesis; that is, there is a cyclic variation in the percentage of recognizable erythroid precursors with a cycle length identical to that of the myeloid precursors (3) .
Although the basic defect responsible for the periodic marrow proliferation in this disorder is not known, recent studies have demonstrated that the urinary excretion of a stimulator of in vitro granulocyte colony formation (colony-stimulating activity; CSA)' also cycles, with peak activity coinciding with the nadir and rising phase of the peripheral blood neutrophil count (4) . Since controversy exists as to whether CSA represents a primary humoral regulator (5) , it becomes important to examine the behavior of other humoral regulators in this setting.
The studies reported here were designed to determine the role of erythropoietin (ESF) in the regulation of erythropoiesis in the grey collie and to examine the relationship of the blood O2 carrying capacity to ESF and red cell production. In 
METHODS
Dogs. Four grey (two males, two females) and two normal collies (one male, one female) were studied. Their handling and care have been described previously (2).
Hematology. Blood samples (2-8 ml) were obtained from the cephalic vein at the same time each day for serum and cell counts. The hematocrit and white blood counts were done by standard techniques, and the reticulocyte percentage was determined from air-dried smears by counting the number of reticulocytes in 1,000 red cells, as previously described (2) . Iron determinations were performed on each serum specimen by the method of Schade, Oyama, Reinhart, and Miller (6) .
ESF bioassay. The in vivo quantitation of ESF was performed by using ex-hypoxic polycythemic mice (7). Grey collie or normal dog serum was given as a single intraperitoneal injection in a volume of 0.4 ml to groups of five mice on the 4th day after the removal of the assay animals from the hypobaric chamber. 48 h later, 59Fe as ferrous citrate in saline was injected intraperitoneally. The red cells were harvested by retro-orbital bleeding 48 h after isotopic administration, washed, and analyzed for radioactivity in a well-type NaI crystal scintillation counter (Nuclear-Chicago Corp., Des Plaines, Ill.). Quantitation of serum ESF was achieved by comparing mean values of 69Fe incorporation in groups of mice receiving test material with a simultaneously determined ESF International Reference Preparation (IRP) dose/response curve.
Erythtropoietic response to phlebotomy and hypertransfwrion. During the course of study, two normal and two grey collies were phlebotomized approximately 10 and 20%o of their blood volume; two additional grey collies were hypertransfused with washed homologous red cells. Daily blood samples were obtained to determine the effects of the phlebotomy and hypertransfusion on reticulocyte and granulocyte cycling and on ESF production.
In vitro studies of hemoglobin synthesis. The bone marrow cell culture technique utilized was modified from that of Krantz, Gallien-Lartigue, and Goldwasser (8) The plates were incubated for 36 h in a 100%o humidity, 95%o air-5%o C02 tissue culture incubator (National Appliance Co., Portland, Ore.). 0.5 gCi of 5Fe tagged to autologous serum in a volume of 0.1 ml (40%o serum/60% NCTC-109) was added to each plate, and the incubation was continued for 12 h.
At the end of the 48-h culture period the cells were harvested with a Pasteur pipette, suspended in phosphate buffered saline (pH 7.4), and centrifuged at 200 g for 10 min at 4'C. The lysate was then acidified with 0.1 ml 2 N HC1 and vortex mixed, and cyclohexanone was added. The aqueous and organic layers were thoroughly vortex mixed and centrifuged at 2,000 g for 30 min at 4VC, and then the organic layer was removed for determination of radioactivity.
Basic aspects of the dog marrow culture system are shown in Figs. 1 and 2 . The relationship between labeled heme recovered and cell number plated was linear over a range of 106-5 X 10' cells/dish, and the regression of this relationship passed through the origin (Fig. 1) . Appropriately, increased heme synthesis was observed in direct relationship to the dose of ESF added (Fig. 2) . The dog marrow culture system is sensitive to added ESF at levels of 0.001-0.002 IRP U/dish, and the response is generally linear above 0.003 U. In all of the experiments employing ESF, doses were chosen to fall well within the linear portion of the dose/response curve. Reproducibility of the assay gives estimates of activity of serum specimens which vary by no more than 25% on repeated measurement.
Endogenous levels of ESF in grey collie sera were assayed in vitro by this method. A direct comparison of multiple serum samples was possible after equalizing the cold iron pool (serum iron concentration) in each sample. This was necessary since previous studies in this laboratory demonstrated the profound influence of the serum iron concentration on "9Fe uptake. Since this is a complex relationship and not strictly dilutional,' it was necessary to add elemental iron in appropriate amounts to the various dog sera. To accomplish this, ferric chloride in normal saline was prepared in a concentration of 1 mg of elemental iron/ml and citrated. Microliter quantities of the iron salt solution were then added to the sera. The iron concentration chosen was the highest concentration observed among the specimens to be compared. The cultures were then processed as described above.
To confirm that any fluctuations found in endogenous hemoglobin-stimulating activity were, in fact, likely due to ESF, antiserum capable of neutralizing the biological activity of ESF was added to selected sera in a separate experiment. The antiserum had been prepared in rabbits against human urinary ESF after the method of Schooley and Garcia (9) . A neutralizing capacity of 5 IRP U/ml of antiserum had been established by bioassay techniques.
Normal rabbit serum was added in equal volume (25 lAg) to control cultures.
To examine the possible role of inhibitors of ESF or hemoglobin synthesis, serum obtained at various times in the 11-12-day cycle was added to normal dog marrow cells in vitro up to a final concentration of 83% by volume, and the effect on basal and ESF-stimulated heme synthesis was measured. Simultaneously established cultures with normal collie serum of equal iron content and at equal serum concentrations served as controls.
The results determined from the in vitro experiments were expressed as basal and net labeled heme recovered (ESF-stimulated minus basal activity).
RESULTS
Hematology. The hematocrits and reticulocyte counts of the normal control collies averaged 42.7 and 1.2%, (SEM 0.3 and 0.1, respectively) ( Fig. 3) . Granulocyte counts ranged from 4-9 X 103/mm3, and there was no evidence of cyclic fluctuation in any of these parameters. In contrast, as shown in Fig. 4 mm3 with cycle times of about 12 days. As previously described (2), a secondary peak in the granulocyte count was observed, and the reticulocyte and granulocyte cycles were out of phase with one another. ESF bioassay. Basal levels of ESF in 13 of 14 normal dog serum specimens were undetectable (Fig. 3 ). Saline and normal dog serum rarely stimulated 'Fe incorporation values above 1.5% in the polycythemic mice. In contrast, levels of ESF in the grey collies were frequently measurable and tended to cycle as well. This was particularly evident for grey collie 22 ( Fig. 4a ) which was the more anemic. ESF activity appeared to cycle out of phase with the reticulocyte count, tending to peak when the reticulocyte count was lowest.
Erythropoietic response to phlebotomy and hypertransfusion. After phlebotomy of the control dogs (Fig.  3) , the reticulocyte count (corrected for hematocrit) rose to a peak of about 4% and serum ESF levels, although not exceeding 0.2 IRP U/ml, became consistently measurable. Similar results were seen in the grey collies (Fig. 4) . There was a rise in the reticulocyte count in response to phlebotomy, particularly in dog 28 In the hypertransfused grey collies, the reticulocyte count fell to unmeasurable levels (Fig. 5) . As long as the hematocrit was substantially elevated no reticulocytes were observed in circulation. As the hematocrit returned toward pretransfusion levels, reticulocytes reappeared and cycling activity commenced again. Through the period of hypertransfusion and recovery there was no detectable alteration in the height of the peaks of granulocyte counts or in the granulocyte cycle time, and once the reticulocyte cycles were reestablished, they retained their previous temporal relationship to the granulocyte cycles.
In vitro studies of hemoglobin synthesis. To demonstrate the responsiveness of the in vitro system to physiologic changes in ESF, sera obtained from the normal doge pre-and post-phlebotomy were adjusted for iron content and added to cells in culture. As shown in Fig.   6 there was a prompt rise in 59Fe-labeled heme stimulated by post-phlebotomy samples, indicating a rise in endogenous ESF. The addition of rabbit anti-ESF serum to post-phlebotomy serum samples completely inhibited the increase in heme labeling; normal rabbit serum had no effect.
Similar studies with grey collie serum confirmed the cycling nature of ESP much more precisely, as shown in Fig. 7 . The cycle activity, as predicted by bioassay, fell out of phase with the reticulocyte count and had the characteristic interval of about 12 days. As estimated by simultaneously determined ESF dose/response curves in vitro, serum ESF activity varied from 0.02 to 0.4 U/ml. When normal dog serum was assayed in an analogous manner, no consistent or periodic change in assayable ESF levels was observed (Fig. 8) .
The addition of anti-ESF serum to separately established cultures completely blocked the variation in basal heme synthesis (Fig. 9) , implying that, in fact, the stimulating activity being measured was ESF. Normal rabbit serum had no effect on heme synthesis.
As the concentration of normal or grey collie serum was increased in culture there was first a rise, followed by a decline in basal (no exogenous ESF) heme synthesis. At no concentration did grey collie serum inhibit hemoglobin synthesis to levels below those seen with normal dog serum. When by the demonstration that cyclic hematopoiesis can be established in normal dogs by transplantation of grey collie marrow (11) . Although these findings appear to remove host factors as possible determinants of the syndrome, the exact nature of the regulatory defect remains unknown. While it has been shown previously that urinary CSA cycles in these animals, the state of CSA as a primary regulator of granulopoiesis, analogous to ESF, remains unresolved. Consequently, the studies reported here have concentrated on the question of humoral regulation in the observed cyclic erythropoiesis by both direct measurements of ESF levels as well as the effect of phlebotomy and hypertransfusion on ESF and reticulocyte production. Before phlebotomy, ESF appears to cycle in grey collies in a fashion not observed in similarly studied normal dogs. Serum ESF levels in the grey collies were generally higher than levels in normal dogs, however, clear Studies of ESF cycling both pre-and post-phlebotomy indicate that ESF and the reticulocyte count are out of phase. By replotting marrow and reticulocyte count data from the previously published studies (2, 3) ESF levels appear to be highest at a time when few pronormoblasts are evident in the marrow. Thus, serum ESF levels risê + anti ESF and approach maximum values 1-2 days before the appearance of recognizable red cell precursors in the bone 5 6 7 8 marrow (Fig. 10) . It is possible to speculate that the in vivo bone marrow response to ESF is intact and that y on endogenous ESF the reticulocyte cycles are a direct consequence of erythayed in vitro. The sera ..
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Marrow utilization of ESF is another possible explanation for the cycling of the hormone in this setting (15) . It has long been recognized that the initial ESF response to anemia or hypoxia is muted within a period of hours or days (16) (17) (18) . It has been postulated that as erythroid proliferation progresses, ESF is utilized by the expanding marrow and serum levels fall. This possibility, although attractive in many ways, again is made unlikely by several observations. First, since this thesis was advanced, a number of direct attempts to document marrow utilization of ESF have failed, including studies in dogs (19, 20) . Secondly, the pattern of the ESF response to hypoxia has recently been shown to be due to the gradual enhancement of tissue oxygen delivery achieved by a decreased hemoglobin affinity for oxygen-a rightward shift in the oxygen-hemoglobin dissociation curve (21) . Consistent with this observation are studies over a wide hematocrit range in humans which have failed to show differences in ESF excretion on the basis of the degree of marrow erythroid proliferation (22) . Finally, studies in human cyclic neutropenia clearly demonstrate that ESF rises and remains elevated for a period of time seemingly inconsistent with marrow utilization as the cause for eventual hormone decline (14) . Nonetheless, marrow utilization of ESF remains a possibility.
Another entirely speculative but possible explanation for ESF cycling is that there is regulatory feedback from proliferating marrow cells on the synthesis of humoral regulators. Thus, as the bone marrow achieves a certain state of proliferation or a particular cell compartment attains critical size, there is suppression of the biogenesis of ESF. This interpretation would be in concert with several abservations relating to serum or urine ESF levels in patients around the time of Fi-ZURE 9 The effect of anti-ESF serum on fluctuations in endogenous serum ESF levels in the grey collie as assayed in vitro. Neutralization of the erythropoietic stimulating activity of grey collie serum was achieved in each case. Normal rabbit serum had no inhibitory effect on heme synthesis.
recovery from aplastic anemia (23) or during the conversion to normoblastic erythroid hyperplasia after correction of folate or vitamin B12 deficiency (24, 25) . In these instances, ESF levels fall before any increase in hemoglobin or hematocrit. In the cases of marrow aplasia, it seemed reasonable to hypothesize increased utilization of ESF with the onset of erythroid proliferation. This explanation seems less tenable, however, in those patients whose marrow already shows marked erythroid hyperplasia at the outset. Feedback regulation of ESF biogenesis could account for both of these observations. FIGURE 10 The temporal relationship between endogenous ESF, marrow pronormoblasts, and the reticulocyte count in the grey collie dog. The relationship between ESF and reticulocyte peaks was derived from the study shown in Fig. 7 and then extrapolated to the relationship between marrow pronormoblasts and reticulocytes for other grey collies as previously published by Dale, Ward, Kimball, and Wolff (3).
Cycling of reticulocytes in normal dogs (26) and of granulocytes in cyclophosphamide-treated dogs (27) has been reported by Morley and Stohlman. They were able to shift the phase of the underlying cycles of reticulocytes and granulocytes in their animals by phlebotomy/ retransfusion and the administration of antineutrophilic serum, respectively. The maneuvers described here failed to alter the basic periodicity or the temporal relationship between reticulocytes and neutrophils. In addition, the administration of antineutrophilic serum to grey collies left unaltered the underlying neutrophil cycles.' Consequently, the periodic nature of this syndrome appears much more deeply entrained than that reported in the normal or marrow-suppressed animal.
A final point derived from these studies relates to the question of stem cell competition or demand for granulocytic or erythrocytic production (28, 29) . In this study, none of the procedures employed to manipulate peripheral counts affected the levels or periodicity of other blood elements. This included a period of 40 days of virtually complete erythroid suppression achieved by hypertransfusion (Fig. 5 ). While such competition for expression may be the nature of the defect, as suggested by Patt, Lund, and Maloney (30), these studies would not support that hypothesis.
While the mechanism of ESF cycling in this syndrome and in human cyclic hematopoiesis is not known, the data clearly show that periodic fluctuation of longrange humoral regulators is an integral part of the syndrome.
